IVI MEMBER SPOTLIGHT: Dr. Wayne Burton
For our first Member Spotlight, we chatted with Dr. Wayne Burton about what he sees as the future of value assessment. Dr. Burton has been with IVI almost since its inception. This interview is an adaptation of a conversation we had with Dr. Burton this fall. Tell us a little about yourself and […]
IVI MEMBER SPOTLIGHT: Andrea Maresca, MPH
Earlier this fall, we sat down with Andrea Maresca, an IVI Board Member, who recently joined our organization. We are thrilled to have an expert in federal and state healthcare policy as part of our organization. Tell us a little about your background and how you came to be connected with IVI. […]
IVI MEMBER SPOTLIGHT: The Alliance for Aging Research
In late January, we sat down with Michael Ward from of IVI’s newest members, The Alliance for Aging Research. We are so pleased to partner with such a dynamic organization. Thank you so much for speaking with us today. Could you tell us a little bit about the Alliance for Aging Research? […]
IVI MEMBER SPOTLIGHT: Arthritis Foundation
IVI had a chance to sit down with Anna Hyde, Director of Patient Advocacy at the Arthritis Foundation to discuss the organization’s goals and how they are getting involved with value assessment. Tell us a little bit about the Arthritis Foundation and its mission and goals. The Arthritis Foundation is boldly pursuing a cure for […]
IVI MEMBER SPOTLIGHT: The Assistance Fund
Over the summer, we sat down with Stephanie Marshall, Director of Advocacy from The Assistance Fund to learn more about the organization and their priorities for the future of value assessment. Tell us a little about your organization. The Assistance Fund (TAF) is an independent 501(c)3 patient assistance organization. We help patients and families facing […]
The Future Of Value Assessment In A Post-Pandemic United States
We begin our Health Affairs blog series with the Global Liver Institute’s Donna Cryer sharing insights on how the pandemic has altered our views about how we measure value and how it influences access to quality care. Donna offers three axioms for value assessment: 1) We are all connected; 2) We are all essential; and […]
How COVID Can Help Us Refocus On The How And Why Of Value Assessment
Our second post in the Health Affairs blog series explores how value assessment can bridge the gap between healthcare consumption and payment decisions. Mark Linthicum, Darius Lakdawalla, and Chuck Phelps discuss emerging methods to capture scientific spillover, patients’ lived experience, and risk. Read the full blog post here. About the Blog Series The Innovation and […]
The US Should Change Payment To Make Health Care More Equitable
The Health Affairs series continues with a post by Amol Navathe, Risa Lavizzo-Mourey and Joshua Laio examining how fee for service and risk-based payments fuel inequities and four ways we can set an explicit intention to use payments to eradicate inequities. The authors’ four recommendations: Form diverse coalitions with shared principles focused on payment Create equity […]
Value Must Be Inclusive
Author: Rick Chapman, PhD, Chief Science Officer In the context of value assessment, what does patient representativeness mean? A new infographic from IVI, “Value assessment should serve diverse populations and the organizations that provide their care,” shows the wide-ranging breadth of factors that comprise patient representativeness. IVI endeavors to fully integrate the patient experience into […]
IVI Drug Pricing Proposal Statement
Jennifer Bright, Executive Director, Innovation and Value Initiative, issued the following statement on Biden Administration and Congressional Democrats drug pricing proposals. “While exercising government levers to address drug pricing and pricing transparency are needed, the current proposals miss the mark on real solutions to improve affordability and to understand whether healthcare spending actually delivers the […]